Promino Nutritional Sciences Inc.
MUSL
CNSX
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 115.60K | 384.00K | 610.60K | 373.00K | 181.70K |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 115.60K | 384.00K | 610.60K | 373.00K | 181.70K |
| Cost of Revenue | 141.70K | 456.50K | 371.90K | 282.50K | 114.60K |
| Gross Profit | -26.10K | -72.50K | 238.70K | 90.50K | 67.10K |
| SG&A Expenses | 433.50K | 641.50K | 607.90K | 669.50K | 537.70K |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 576.70K | 1.10M | 981.60K | 955.80K | 654.10K |
| Operating Income | -461.10K | -720.40K | -371.00K | -582.80K | -472.40K |
| Income Before Tax | -294.40K | -966.00K | 144.90K | -947.20K | -373.20K |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -294.40K | -966.00K | 144.90K | -947.20K | -373.20K |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -294.40K | -966.00K | 144.90K | -947.20K | -373.20K |
| EBIT | -461.10K | -720.40K | -371.00K | -582.80K | -472.40K |
| EBITDA | -- | -- | -- | -- | -- |
| EPS Basic | 0.00 | -0.01 | 0.00 | -0.01 | 0.00 |
| Normalized Basic EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS Diluted | 0.00 | -0.01 | 0.00 | -0.01 | 0.00 |
| Normalized Diluted EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Average Basic Shares Outstanding | 164.25M | 136.23M | 136.39M | 136.05M | 118.38M |
| Average Diluted Shares Outstanding | 164.25M | 136.23M | 136.39M | 136.05M | 118.38M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |